Medtronic plc (NYSE:MDT) SVP Carol A. Surface sold 15,000 shares of the business’s stock in a transaction on Monday, December 28th. The stock was sold at an average price of $114.90, for a total transaction of $1,723,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
MDT stock opened at $117.14 on Friday. The company has a quick ratio of 1.79, a current ratio of 2.16 and a debt-to-equity ratio of 0.52. Medtronic plc has a twelve month low of $72.13 and a twelve month high of $122.15. The stock has a market capitalization of $157.67 billion, a price-to-earnings ratio of 44.71, a price-to-earnings-growth ratio of 3.58 and a beta of 0.69. The firm’s fifty day simple moving average is $113.17 and its two-hundred day simple moving average is $104.05.
Medtronic (NYSE:MDT) last posted its quarterly earnings data on Monday, November 23rd. The medical technology company reported $1.02 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.22. Medtronic had a net margin of 12.69% and a return on equity of 9.71%. The business had revenue of $7.65 billion for the quarter, compared to analysts’ expectations of $7.05 billion. During the same quarter in the previous year, the business posted $0.45 earnings per share. As a group, equities research analysts expect that Medtronic plc will post 4.2 EPS for the current year.
A number of hedge funds have recently bought and sold shares of MDT. BlackRock Inc. increased its position in Medtronic by 4.1% during the second quarter. BlackRock Inc. now owns 111,209,886 shares of the medical technology company’s stock valued at $10,197,948,000 after acquiring an additional 4,352,426 shares during the last quarter. Two Sigma Advisers LP grew its holdings in shares of Medtronic by 393.8% in the second quarter. Two Sigma Advisers LP now owns 1,574,920 shares of the medical technology company’s stock worth $144,420,000 after purchasing an additional 1,255,988 shares during the last quarter. Coho Partners Ltd. bought a new position in shares of Medtronic in the third quarter worth about $124,511,000. Nuveen Asset Management LLC grew its holdings in shares of Medtronic by 14.3% in the third quarter. Nuveen Asset Management LLC now owns 7,627,002 shares of the medical technology company’s stock worth $792,599,000 after purchasing an additional 955,250 shares during the last quarter. Finally, Polar Capital LLP grew its holdings in shares of Medtronic by 159.2% in the third quarter. Polar Capital LLP now owns 1,169,376 shares of the medical technology company’s stock worth $121,522,000 after purchasing an additional 718,244 shares during the last quarter. Institutional investors and hedge funds own 68.87% of the company’s stock.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.
Featured Article: Price to Earnings Ratio (PE)
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.